Article Name Point of Care Testing
The FDA's Breakthrough Devices Program is intended to expedite the development and FDA review of medical devices granted BDD
08th October, 2025
The self-collected option allows patients to collect their own sample in private, eliminating the need for a pelvic exam
01st October, 2025
The 17,000-woman study, led by Peking University Shenzhen Hospital, sets three world records and integrates PHASiFY™ DNA concentration technology with AI-powered diagnostics to advance scalable, non-invasive screening in line with WHO’s 2030 elimination goals.
23rd September, 2025
The collaboration introduces BD Rowa™ Vmax robotic technology to deliver 24/7 prescription access, streamline pharmacy operations, and empower staff to focus on patient-centred care.
23rd September, 2025
The new CLIA-waived immunoassay enables simultaneous detection of influenza A/B and SARS-CoV-2 in just 10 minutes, supporting faster, cost-effective decision-making at the point of care.
23rd September, 2025
The Institute, led by Dr. Shyam Sathanandam, is transforming neonatal cardiac care by delivering minimally invasive PDA closures directly in the NICU—eliminating transport risks and accelerating recovery for South Florida’s most vulnerable infants.
23rd September, 2025
The landmark centre, inaugurated by Delhi’s Chief Minister Smt. Rekha Gupta, sets a global benchmark in women-centric cancer care with a focus on dignity, privacy, and advanced treatment outcomes.
23rd September, 2025
Breakthrough bioactive glass device offers surgeons a safe, resorbable, and cost-effective alternative to metal implants, engineered to accelerate bone regeneration and streamline surgical workflow.
11th September, 2025
Breakthrough approval supports home-based testing and strengthens access to care
10th September, 2025
Alliance integrates Siemens’ digital pathology solutions with Evident’s Pramana platform to modernize diagnostics, unify clinical workflows, and advance AI-driven personalised healthcare in Germany.
04th September, 2025
MI Cancer Seek is the first and only test to combine whole exome sequencing (WES) and whole transcriptome sequencing (WTS) with FDA-approved CDx indications
18th August, 2025
New system empowers sterile processing departments with the fastest FDA-cleared readout on the market, enabling real-time decision-making and elevating operational efficiency.
08th August, 2025
Hyperfine Achieves Clinical Milestone Ahead of Plan With 100th Patient Enrolled in Neurology Office Study Using the Next-Generation Swoop® System
05th August, 2025
In conversation with MedTech Spectrum, Mr. Wong Yau Chung, Group CEO of Advanced MedTech Holdings, shares how the company is advancing kidney stone care, laser technologies, and digital platforms to address emerging urological challenges.
04th August, 2025
Milestone underscores ClariMed’s commitment to quality excellence and reinforces its position as a trusted partner in navigating complex global regulatory landscapes
30th July, 2025
Strategic collaboration aims to accelerate validation and commercialisation of non-invasive tests, enabling earlier, more accessible diagnosis of Alzheimer’s disease
30th July, 2025
New devices designed to streamline and personalize HYQVIA® administration for patients receiving subcutaneous immune globulin therapy
22nd July, 2025
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer